Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

Comment by lscfaon Sep 28, 2015 1:01pm
306 Views
Post# 24141436

RE:Craigbad complete idiot to rely on accounting earnings

RE:Craigbad complete idiot to rely on accounting earningsCXR target price $119.80, upside 77%
VRX target price $386.45, upside 47%
MSL target price $3.98, upside 113%


https://www.stockhouse.com/companies/earnings/t.cxr/concordia-healthcare-corp-common-shares
https://www.stockhouse.com/companies/earnings/t.vrx/valeant-pharmaceuticals-international-inc
https://www.stockhouse.com/companies/earnings/t.msl/merus-labs-international-inc

lscfa wrote:
Latest Quarterly results....

CXR loss per share $0.02 US, share price $67.63 CDN....
VXR loss per share $0.15 US, share price $263.19 CDN....
MSL loss per share $0.02 CDN, share price $1.87 CDN



<< Previous
Bullboard Posts
Next >>